Aidan Thompson is Chief Commercial Officer at Stead Impact Ventures, a family office investment firm focused on neurodegenerative diseases, metabolic health, and mental health. He leads commercialization and strategic advisory across the portfolio, helping founders and company leadership translate scientific and technical innovation into scalable businesses with emphasis on market focus, early traction, and investor readiness, ensuring product, strategy, and execution are aligned to build durable, defensible value. Aidan holds a PhD in Neuroscience and Biomechanics and is recognized for his structured, outcome-driven approach to market development and scaling innovation.
